Skip to content

Elmind Capital, LP

Follow

13F filer, CIK 2052213, NEW YORK, NY

Elmind Capital, LP reported $403,836,290 across 30 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 65.12% of the portfolio.

Accepted , ingested 13F-HR 0001013594-26-001197

Period
2026-09-30
Reported value
$404M
Holdings
30
Top 10 weight
65.12%
New
0
Sold out
5

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AMLXadded+782,760$22.8M
LEGNadded+999,107$19.9M
URGNadded+371,100$15.1M
IMCRadded+175,000$5.3M
VRDNadded+240,000$4.94M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
COGTreduced-303,998-$9.73M
INSMexited-65,000-$6.93M
SNDXreduced-250,000-$4.7M
PTGXexited-38,000-$4.66M
PCVXreduced-80,000-$4.55M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001013594-26-001197, largest first. % of portfolio is the value over $403,836,290, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 865,000 shares; 2026Q1: 865,000 shares; 2026Q2: 990,000 shares; 2026Q3: 1,110,000 shares 1,110,000$36M8.91%+120,000Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 570,569 shares; 2026Q3: 1,569,676 shares 1,569,676$31.2M7.73%+999,107Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,855,000 shares; 2026Q1: 1,855,000 shares; 2026Q2: 1,855,000 shares; 2026Q3: 1,605,000 shares 1,605,000$30.2M7.47%-250,000Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,170,740 shares; 2026Q1: 1,170,740 shares; 2026Q2: 1,170,740 shares; 2026Q3: 866,742 shares 866,742$27.8M6.87%-303,998Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 536,946 shares; 2026Q1: 536,946 shares; 2026Q2: 1,465,279 shares; 2026Q3: 1,465,279 shares 1,465,279$26.4M6.55%0Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 112,000 shares; 2026Q1: 112,000 shares; 2026Q2: 112,000 shares; 2026Q3: 894,760 shares 894,760$26M6.45%+782,760Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 858,631 shares; 2026Q1: 534,931 shares; 2026Q2: 984,931 shares; 2026Q3: 1,224,931 shares 1,224,931$25.2M6.25%+240,000Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 291,500 shares; 2026Q1: 316,500 shares; 2026Q2: 452,340 shares; 2026Q3: 372,340 shares 372,340$21.2M5.25%-80,000Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 100,000 shares; 2026Q1: 220,000 shares; 2026Q2: 120,000 shares; 2026Q3: 491,100 shares 491,100$20M4.94%+371,100Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 110,000 shares; 2026Q1: 177,600 shares; 2026Q2: 292,600 shares; 2026Q3: 322,600 shares 322,600$19M4.7%+30,000Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 310,000 shares; 2026Q1: 530,000 shares; 2026Q2: 690,000 shares; 2026Q3: 962,792 shares 962,792$14.8M3.66%+272,792Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 475,750 shares; 2026Q1: 475,750 shares; 2026Q2: 525,750 shares; 2026Q3: 455,750 shares 455,750$14.5M3.58%-70,000Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 482,500 shares; 2026Q1: 482,500 shares; 2026Q2: 436,518 shares; 2026Q3: 436,518 shares 436,518$14.1M3.49%0Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 700,000 shares; 2026Q1: 4,550,000 shares; 2026Q2: 4,550,000 shares; 2026Q3: 4,550,000 shares 4,550,000$12.4M3.06%0Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 476,338 shares; 2026Q1: 476,338 shares; 2026Q2: 476,338 shares; 2026Q3: 476,338 shares 476,338$11.6M2.88%0Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 460,000 shares; 2026Q1: 460,000 shares; 2026Q2: 460,000 shares; 2026Q3: 460,000 shares 460,000$10.9M2.7%0Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 493,820 shares; 2026Q3: 493,820 shares 493,820$8.35M2.07%0Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 11,000 shares; 2026Q1: 15,000 shares; 2026Q2: 15,000 shares; 2026Q3: 15,000 shares 15,000$8.13M2.01%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 58,248 shares; 2026Q1: 58,248 shares; 2026Q2: 81,143 shares; 2026Q3: 256,143 shares 256,143$7.76M1.92%+175,000Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 22,000 shares; 2026Q1: 22,000 shares; 2026Q2: 22,000 shares; 2026Q3: 22,000 shares 22,000$7.32M1.81%0Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 130,000 shares; 2026Q2: 130,000 shares; 2026Q3: 749,560 shares 749,560$5.54M1.37%+619,560Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 2,150,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 520,000 shares; 2026Q3: 520,000 shares 520,000$4.33M1.07%0Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,037 shares; 2026Q3: 228,265 shares 228,265$3.68M0.91%+196,228Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 211,000 shares; 2026Q1: 211,000 shares; 2026Q2: 91,000 shares; 2026Q3: 61,000 shares 61,000$3.58M0.89%-30,000Timeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 265,000 shares; 2026Q2: 265,000 shares; 2026Q3: 265,000 shares 265,000$3.12M0.77%0Timeline
SUPNSUPERNUS PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares; 2026Q2: 70,000 shares; 2026Q3: 70,000 shares 70,000$3.01M0.75%0Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 82,000 shares; 2026Q1: 47,000 shares; 2026Q2: 47,000 shares; 2026Q3: 47,000 shares 47,000$2.82M0.7%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 49,444 shares; 2026Q3: 49,444 shares 49,444$1.93M0.48%0Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 900,000 shares; 2026Q1: 900,000 shares; 2026Q2: 900,000 shares; 2026Q3: 915,902 shares 915,902$1.69M0.42%+15,902Timeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 207,900 shares; 2026Q1: 207,900 shares; 2026Q2: 107,900 shares; 2026Q3: 107,900 shares 107,900$1.36M0.34%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
INSMINSMED INC65,000$6.93Mshares
PTGXPROTAGONIST THERAPEUTICS INC38,000$4.66Mshares
WVEWAVE LIFE SCIENCES LTD177,846$1.03Mshares
TYRATYRA BIOSCIENCES INC20,000$639Kshares
ENGNENGENE THERAPEUTICS INC210,000$363Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001013594-26-001197 base2026-11-16